Cargando…

Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

BACKGROUND: Sclerostin is a Wnt pathway antagonist regulating osteoblast activity and bone turnover. Here, we assessed the potential association of sclerostin with the development of coronary artery (CAC) and aortic valve calcifications (AVC) in haemodialysis (HD) patients. METHODS: We conducted a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandenburg, Vincent M, Kramann, Rafael, Koos, Ralf, Krüger, Thilo, Schurgers, Leon, Mühlenbruch, Georg, Hübner, Sinah, Gladziwa, Ulrich, Drechsler, Christiane, Ketteler, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851854/ https://www.ncbi.nlm.nih.gov/pubmed/24112318 http://dx.doi.org/10.1186/1471-2369-14-219

Ejemplares similares

Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial
por: Saritas, Turgay, et al.
Publicado: (2022)

The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020)

Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles
por: Schurgers, Leon J., et al.
Publicado: (2018)

Sclerostin Protects Against Vascular Calcification Development in Mice
por: De Maré, Annelies, et al.
Publicado: (2022)

Serum sclerostin in vascular calcification in CKD: a meta-analysis
por: Lin, Yan, et al.
Publicado: (2023)

Serum sclerostin is an independent predictor of mortality in hemodialysis patients
por: Gonçalves, Flávia Letícia Carvalho, et al.
Publicado: (2014)

Circulating miRNA-29b and Sclerostin Levels Correlate with Coronary Artery Calcification and Cardiovascular Events in Maintenance Hemodialysis Patients
por: He, Jiqing, et al.
Publicado: (2021)

Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone–Vascular Axis
por: De Maré, Annelies, et al.
Publicado: (2019)

Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes
por: Medeiros, Maria Carolina, et al.
Publicado: (2020)

What is the relationship between sclerostin and cardiovascular events in hemodialysis patients?
por: Zhao, Yu, et al.
Publicado: (2020)

Development of the BioHybrid Assay: Combining Primary Human Vascular Smooth Muscle Cells and Blood to Measure Vascular Calcification Propensity
por: Jaminon, Armand M. G., et al.
Publicado: (2021)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Arterial calcifications
por: Rennenberg, Roger J M W, et al.
Publicado: (2010)

High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification
por: Scheiber, Daniel, et al.
Publicado: (2015)

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
por: Kuczera, Piotr, et al.
Publicado: (2016)

Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
por: Lu, Jing-Wun, et al.
Publicado: (2022)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Experience With Anti-Sclerostin Antibody for Osteoporosis Patient With End-Stage Renal Disease on Hemodialysis
por: Mukaddam, Mona Al, et al.
Publicado: (2021)

Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees
por: Rapp, Nikolas, et al.
Publicado: (2020)

Pharmacological and Nutritional Modulation of Vascular Calcification
por: Vossen, Liv M., et al.
Publicado: (2019)

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future
por: Brandenburg, Vincent, et al.
Publicado: (2022)

Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle Cells
por: Kaczor, Dawid M., et al.
Publicado: (2022)

Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK)
por: Haroon, Sabrina, et al.
Publicado: (2023)

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients – Data from the German Calciphylaxis Registry
por: Rothe, Hansjörg, et al.
Publicado: (2017)

Vitamin K2 Needs an RDI Separate from Vitamin K1
por: Akbulut, Asim Cengiz, et al.
Publicado: (2020)

The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes
por: Jaminon, Armand, et al.
Publicado: (2019)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis
por: Chen, Aiqun, et al.
Publicado: (2018)

Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis
por: Turoń-Skrzypińska, Agnieszka, et al.
Publicado: (2020)

Magnesium Improves Cardiac Function in Experimental Uremia by Altering Cardiac Elastin Protein Content
por: Barros, Xoana, et al.
Publicado: (2023)

The Phosphorus and the Vascular Calcification in ESRD between Old Adventures and New Horizons
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2011)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)

Drug discovery of sclerostin inhibitors
por: Yu, Sifan, et al.
Publicado: (2022)

Missense mutation of VKORC1 leads to medial arterial calcification in rats
por: Michaux, Arnaud, et al.
Publicado: (2018)

The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts
por: Pigeaud, Karina E., et al.
Publicado: (2023)

Whole body calcification in a hemodialysis patient
por: Yildirim, M., et al.
Publicado: (2016)

Serum Calcification Propensity in Children on Chronic Hemodialysis
por: Kakajiwala, Aadil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t8atg5og5m1cojpvnesq93jm2a